Innovative Drug Delivery Zosano Pharma's proprietary transdermal system offers rapid and consistent drug delivery, addressing unmet needs for fast-acting therapeutics across various indications. This presents opportunities to partner with healthcare providers and pharmaceutical companies seeking improved delivery options for existing drugs.

Market Leadership Potential Focusing on CNS conditions and rapid symptom relief, the company's technology aligns with increasing demand for non-invasive, easy-to-use treatment formats, positioning Zosano as a competitive partner for companies aiming to differentiate their product portfolios.

Recent Asset Acquisition Following the sale of assets to Emergex Vaccines in October 2022, there is a shift in Zosano's strategy, creating potential opportunities to collaborate or acquire innovative technologies within vaccine or therapeutic development pipelines.

Financial Growth Opportunities With recent funding and a revenue range of up to $100 million, there are opportunities to engage with Zosano for pilot programs, joint research, or co-development projects to expand their application scope and accelerate market penetration.

Technological Edge Leveraging a tech stack involving AWS, cloud platforms, and modern development tools, Zosano demonstrates strong infrastructure capabilities, which can be valuable for scalable collaborations in digital health, clinical trials, or data management solutions.